CYTEK BIOSCIENCES, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was -$34.00K, a 100.49% decline year-over-year.
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was -$29.00K, a 100.24% decline year-over-year.
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for fiscal 2025 was $15.07M, a 30.25% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for fiscal 2024 was $21.61M, a 51.05% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for fiscal 2023 was $44.15M.
- CYTEK BIOSCIENCES, INC. payments for repurchase of common stock for fiscal 2022 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$63.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $4.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.07M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $22.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $34.04M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.63M 10-Q · filed 2026-05-07 | $32.23M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.00M 10-K · filed 2026-02-26 | $21.61M 10-K · filed 2026-02-26 |
| 2024-09-30 | $11.90M 10-Q · filed 2024-11-07 | $49.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.70M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $34.60M 10-K · filed 2026-02-26 | $44.15M 10-K · filed 2026-02-26 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |
| 2021-12-31 | $0.00 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |